310 related articles for article (PubMed ID: 21060333)
21. Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization.
Lidar M; Scherrmann JM; Shinar Y; Chetrit A; Niel E; Gershoni-Baruch R; Langevitz P; Livneh A
Semin Arthritis Rheum; 2004 Feb; 33(4):273-82. PubMed ID: 14978665
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever.
Kallinich T; Wittkowski H; Keitzer R; Roth J; Foell D
Ann Rheum Dis; 2010 Apr; 69(4):677-82. PubMed ID: 19762364
[TBL] [Abstract][Full Text] [Related]
23. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
Sante; 2004; 14(4):261-6. PubMed ID: 15745878
[TBL] [Abstract][Full Text] [Related]
24. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health.
Samuels J; Aksentijevich I; Torosyan Y; Centola M; Deng Z; Sood R; Kastner DL
Medicine (Baltimore); 1998 Jul; 77(4):268-97. PubMed ID: 9715731
[TBL] [Abstract][Full Text] [Related]
25. The Relationship Among the Level of Serum Amyloid A, High-Density Lipoprotein and Microalbuminuria in Patients With Familial Mediterranean Fever.
Uslu AU; Aydin B; Icagasıoğlu IS; Balta S; Deveci K; Alkan F; Yıldız G; Sahin A
J Clin Lab Anal; 2016 Nov; 30(6):1003-1008. PubMed ID: 27094695
[TBL] [Abstract][Full Text] [Related]
26. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update.
Cerquaglia C; Diaco M; Nucera G; La Regina M; Montalto M; Manna R
Curr Drug Targets Inflamm Allergy; 2005 Feb; 4(1):117-24. PubMed ID: 15720245
[TBL] [Abstract][Full Text] [Related]
28. Familial Mediterranean Fever: a review for clinical management.
Fonnesu C; Cerquaglia C; Giovinale M; Curigliano V; Verrecchia E; de Socio G; La Regina M; Gasbarrini G; Manna R
Joint Bone Spine; 2009 May; 76(3):227-33. PubMed ID: 19091621
[TBL] [Abstract][Full Text] [Related]
29. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
Bilgen SA; Kilic L; Akdogan A; Kiraz S; Kalyoncu U; Karadag O; Ertenli I; Dogan I; Calguneri M
J Clin Rheumatol; 2011 Oct; 17(7):358-62. PubMed ID: 21946459
[TBL] [Abstract][Full Text] [Related]
30. Higher thrombin activatable fibrinolysis inhibitor levels are associated with inflammation in attack-free familial Mediterranean fever patients.
Bavbek N; Ceri M; Akdeniz D; Kargili A; Duranay M; Erdemli K; Akcay A; Guz G
Ren Fail; 2014 Jun; 36(5):743-7. PubMed ID: 24580410
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory reaction in familial Mediterranean fever (FMF) before and with colchicine therapy.
Ollier-Hartmann MP; Godeau P; Hartmann L
Biomed Pharmacother; 1984; 38(9-10):448-55. PubMed ID: 6529602
[TBL] [Abstract][Full Text] [Related]
32. [Serum amyloid a protein concentrations in patients with familial Mediterranean fever].
Dzhndoian ZT
Georgian Med News; 2011 Dec; (201):48-51. PubMed ID: 22306501
[TBL] [Abstract][Full Text] [Related]
33. Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections.
Çakan M; Aktay Ayaz N; Keskindemirci G; Karadağ ŞG; Tanatar A; Sönmez HE
Clin Rheumatol; 2020 Jan; 39(1):249-253. PubMed ID: 31485845
[TBL] [Abstract][Full Text] [Related]
34. Is Familial Mediterranean Fever a thrombotic disease or not?
Demirel A; Celkan T; Kasapcopur O; Bilgen H; Ozkan A; Apak H; Arisoy N; Yildiz I
Eur J Pediatr; 2008 Mar; 167(3):279-85. PubMed ID: 17436016
[TBL] [Abstract][Full Text] [Related]
35. Familial mediterranean fever: revisiting an ancient disease.
Ozen S
Eur J Pediatr; 2003 Jul; 162(7-8):449-454. PubMed ID: 12751000
[TBL] [Abstract][Full Text] [Related]
36. Concordance between CRP and SAA in familial Mediterranean fever during attack-free period: A study of 218 patients.
Stankovic Stojanovic K; Hentgen V; Fellahi S; Georgin-Lavialle S; Amselem S; Grateau G; Bastard JP; Steichen O
Clin Biochem; 2017 Mar; 50(4-5):206-209. PubMed ID: 27838405
[TBL] [Abstract][Full Text] [Related]
37. Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.
Kiraz S; Ertenli I; Arici M; Calgüneri M; Haznedaroglu I; Celik I; Pay S; Kirazli S
Clin Exp Rheumatol; 1998; 16(6):721-4. PubMed ID: 9844766
[TBL] [Abstract][Full Text] [Related]
38. Assessment of serum neopterin and calprotectin as biomarkers for subclinical inflammation in patients with familial Mediterranean fever.
Tezcan D; Onmaz DE; Sivrikaya A; Hakbilen S; Körez MK; Gülcemal S; Yılmaz S
Ir J Med Sci; 2023 Aug; 192(4):2015-2022. PubMed ID: 36163581
[TBL] [Abstract][Full Text] [Related]
39. Non-response to colchicine in FMF--definition, causes and suggested solutions.
Ben-Chetrit E; Ozdogan H
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S49-51. PubMed ID: 19026114
[No Abstract] [Full Text] [Related]
40. Update on the management of colchicine resistant Familial Mediterranean Fever (FMF).
El Hasbani G; Jawad A; Uthman I
Orphanet J Rare Dis; 2019 Oct; 14(1):224. PubMed ID: 31615541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
